📗 Cite This Artifact
Brain-to-Brain Interface Technology
Overview
Overview
Brain-to-brain interfaces (BTBIs), also known as brain-to-brain communication systems or neural interfaces, represent an emerging class of neurotechnology that enables direct communication between the brains of two or more individuals["@paisvieira2013"]. These systems translate neural signals from one brain into signals that can be interpreted by another brain, bypassing traditional sensory and motor pathways. While primarily explored for basic neuroscience research and potential therapeutic applications, BTBIs have emerging relevance for neurodegenerative disease research, particularly in understanding neural connectivity, developing brain-computer interface (BCI) therapies, and exploring compensatory neural pathways.
History and Development
The field of brain-to-brain communication emerged from the convergence of brain-computer interface (BCI) technology and neuroscience research. Key milestones include:
- 2002: The first demonstration of signal transfer between two rat brains, where sensory information from a rat in Brazil was transmitted to a rat in the United States[@nicolelis2015]
- 2009: Nicolelis and colleagues demonstrated a brain-to-brain interface allowing a rat to control the tail movements of another rat[@nicolelis2015]
- 2013: The first human EEG-based brain-to-brain communication experiment, where participants successfully transmitted words between India and France[@rao2013]
- 2019: Advanced multi-person brain-to-brain communication networks demonstrated with up to three participants[@grau2014]
- 2022-2024: Increased research into therapeutic applications of BTBIs for neurological disorders
Technology Approaches
Invasive BTBIs
Invasive brain-to-brain interfaces utilize implantable electrode arrays that record directly from neural tissue[@ramakrishnan2014]. These systems offer high spatial resolution and signal quality but require surgical implantation.
Key Technologies:
- Utah Arrays: Multi-electrode arrays implanted in motor [cortex](/brain-regions/cortex)
- NeuroPixel Probes: High-density silicon probes with thousands of recording sites
- ECoG Arrays: Electrocorticographic grids placed on the brain surface
- Research into neural pathway reorganization in AD/PD
- Development of next-generation neuroprosthetics
- Understanding compensatory mechanisms in ALS
Non-Invasive BTBIs
Non-invasive BTBIs use external recording methods to capture brain activity without surgery[@rao2013].
Key Technologies:
- Electroencephalography (EEG): Portable, affordable, widely used
- Functional Near-Infrared Spectroscopy (fNIRS): Measures hemodynamic responses
- Transcranial Magnetic Stimulation (TMS): Can stimulate specific brain regions
- Transcranial Direct Current Stimulation (tDCS): Modulates neural excitability
- No surgical risk
- Easier clinical translation
- Lower cost for widespread deployment
- Lower spatial resolution
- Signal contamination from artifacts
- Limited bandwidth for information transfer
Current Research State
Animal Studies
Animal models have demonstrated several key capabilities[@nicolelis2015]:
Human Studies
Human BTI research remains in early stages[@rao2013][@grau2014]:
Ethical Considerations
Brain-to-brain interfaces raise significant ethical questions[@decety2020]:
Privacy and Autonomy
- Can thoughts be read without consent?
- What protections exist for mental privacy?
- How is individual autonomy maintained?
Identity and Agency
- Does BTI alter sense of self?
- Who is responsible for actions influenced by BTI?
- What are the psychological effects of shared consciousness?
Equity and Access
- Will BTI technology exacerbate existing inequalities?
- Who controls access to BTI systems?
- What are the implications for cognitive enhancement?
Safety and Security
- Can BTI systems be hacked?
- What are the neurological risks of long-term use?
- How are adverse effects monitored and addressed?
Neurodegenerative Applications
Alzheimer's Disease
BTBIs offer potential research applications in AD[@paisvieira2013]:
Parkinson's Disease
PD research may benefit from BTI technology[@paisvieira2013]:
Amyotrophic Lateral Sclerosis
BTBIs have particular relevance for ALS[@paisvieira2013]:
Comparison to Standard BCI Approaches
| Feature | Standard BCI | Brain-to-Brain Interface |
|---------|--------------|-------------------------|
| Primary Use | Individual control of devices | Communication between brains |
| Direction | Brain-to-computer | Brain-to-brain |
| Neural Recording | Single individual | Multiple individuals |
| Feedback | Visual/auditory/tactile | Direct neural stimulation |
| Current Development | Clinical trials | Early research |
| Therapeutic Focus | Motor restoration | Communication/collaboration |
Mechanism and Pathway Cross-Links
Related Mechanisms
- [Neural Signal Transduction](/mechanisms/neural-signal-transduction)
- [Synaptic Transmission](/mechanisms/synaptic-transmission)
- [Neuroplasticity](/mechanisms/neuroplasticity)
- [Neural Oscillations](/mechanisms/neural-oscillations)
Related Technologies
- [Brain-Computer Interface](/technologies/brain-computer-interface)
- [Deep Brain Stimulation](/therapeutics/deep-brain-stimulation)
- [Neural Prosthetics](/therapeutics/neural-prosthetics)
Related Diseases
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
See Also
- [Brain-Computer Interface Technologies](/technologies/brain-computer-interfaces)
- [Neural Engineering](/technologies)
- [Neuroethics](/technologies)
- [Neuromodulation](/technologies)
External Links
- [BrainGate Clinical Trials](https://clinicaltrials.gov/ct2/show/NCT00912041)
- [Neuralink Technology](https://neuralink.com/)
- [DARPA's Brain Initiative](https://www.darpa.gov/program/our-research/darpa-and-the-brain-initiative)
References
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: NLRP3, CASP1, IL1B, PYCARD
- [TREM2-Dependent Microglial Senescence Transition](/hypothesis/h-61196ade) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: TREM2
- [Targeted Butyrate Supplementation for Microglial Phenotype Modulation](/hypothesis/h-3d545f4e) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: GPR109A
- [Vagal Afferent Microbial Signal Modulation](/hypothesis/h-ee1df336) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: GLP1R, BDNF
- [Synthetic Biology BBB Endothelial Cell Reprogramming](/hypothesis/h-84808267) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: TFR1, LRP1, CAV1, ABCB1
- [Cell-Type Specific TREM2 Upregulation in DAM Microglia](/hypothesis/h-seaad-51323624) — <span style="color:#81c784;font-weight:600">0.70</span> · Target: TREM2
- [Age-Dependent Complement C4b Upregulation Drives Synaptic Vulnerability in Hippocampal CA1 Neurons](/hypothesis/h-2f43b42f) — <span style="color:#81c784;font-weight:600">0.70</span> · Target: C4B
- [Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming](/hypothesis/h-f3fb3b91) — <span style="color:#81c784;font-weight:600">0.67</span> · Target: TLR4
Related Analyses:
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v3-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v4-20260402) 🔄
- [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v5-20260402) 🔄
Pathway Diagram
The following diagram shows the key molecular relationships involving Brain-to-Brain Interface Technology discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | technologies-brain-to-brain-interface |
| kg_node_id | None |
| entity_type | technology |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-8bc4a49378d2 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'technologies-brain-to-brain-interface'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-technologies-brain-to-brain-interface?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Brain-to-Brain Interface Technology](http://scidex.ai/artifact/wiki-technologies-brain-to-brain-interface)
http://scidex.ai/artifact/wiki-technologies-brain-to-brain-interface